emvododstat: Clinical Trials

5 trials of emvododstat, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 2 completed. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Terminated 3, Completed 2
Phase 21Terminated 1

Follow emvododstat: new trials by email Literature Review of emvododstat trials Research Report on emvododstat

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias
PTC299 - Leukemia, Myeloid, Acute, AML
Phase 1TerminatedPTC Therapeutics332018-10-292022-02-02
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors
VEGF inhibitor PTC299 - Brain and Central Nervous System Tumors
Phase 1CompletedPediatric Brain Tumor Consortium282010-11-012015-05-04
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
VEGF inhibitor PTC299, gene expression analysis, polymerase chain reaction - Kaposi's Sarcoma
Phase 1 / Phase 2TerminatedAIDS Malignancy Consortium172008-09-012018-06-06
PTC299 for Treatment of Advanced Cancer
PTC299, Docetaxel - Advanced Cancer
Phase 1TerminatedPTC Therapeutics762008-07-032019-05-10
PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer
PTC299 - Metastatic Breast Cancer
Phase 1CompletedPTC Therapeutics332007-11-012016-03-03

Conditions studied

Neoplasms (2)  ·  AIDS-related Kaposi sarcoma (1)  ·  Astrocytoma (1)  ·  Breast Neoplasms (1)  ·  Central Nervous System Neoplasms (1)  ·  Familial ependymoma (1)  ·  HIV Infections (1)  ·  Leukemia, Myeloid (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Medulloblastoma (1)  ·  Meningioma (1)  ·  Neoplasms by Histologic Type (1)  ·  Oligodendroglioma (1)  ·  Optic Nerve Glioma (1)  ·  Sarcoma, Kaposi (1)

Sponsors

PTC Therapeutics (3)  ·  AIDS Malignancy Consortium (1)  ·  Pediatric Brain Tumor Consortium (1)

Countries

United States (5)

Top investigators

Gary Schwartz, MD (1)  ·  Jay Barth, MD (1)  ·  Roger J. Packer, MD (1)  ·  Susan E. Krown, MD (1)

NIH funding

U01CA081457 (1), U01CA121947 (1)